<DOC>
	<DOCNO>NCT00275249</DOCNO>
	<brief_summary>The purpose study determine extent analgesic tolerance develop chronic pain patient either start opioids receive increase pre-study opioid dose level observe long-term ( 20 week ) stable opioid therapy . In addition clinical measure relief ongoing chronic pain , estimation tolerance development supplement periodic assessment anti-nociceptive effect opioids use brief thermal sensitization model .</brief_summary>
	<brief_title>Evolution Analgesic Tolerance With Opioids</brief_title>
	<detailed_description>The purpose study determine extent analgesic tolerance develop chronic pain patient either start opioids receive increase pre-study opioid dose level observe long-term ( 20 week ) stable opioid therapy . In addition clinical measure relief ongoing chronic pain , estimation tolerance development supplement periodic assessment anti-nociceptive effect opioids use brief thermal sensitization model .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Levorphanol</mesh_term>
	<criteria>1 . Adults 2180 year age . 2 . Desires opioid dose increase ( approval current prescribe physician ) , opioids desire trial opioids ongoing pain . 3 . Expected remain stable health least six month period surround study participation . 4 . Able willing provide write informed consent . 5 . Able understand follow instruction investigator , include rating scale . 6 . Stable chronic pain either neuropathic nonneuropathic origin define . The diagnosis base history , physical examination , review medical record confirm diagnosis . 7 . For chronic user : stable opioid use 31 150 mg/day morphine equivalent . Stable use define change daily dose opioids month precede study entry . 8 . For na√Øve user : use opioids use less equal 30 mg/day morphine equivalent chronic pain . 9 . Chronic pain must least moderately severe , defined average daily pain severity exceed 40 mm 100 mm pain intensity visual analog scale ( VAS ) . 10 . Female subject must postmenopausal , physically incapable become pregnant , use acceptable birth control method . Acceptable method birth control include hormonal contraceptive doublebarrier method ( condom diaphragm spermicidal agent IUD ) . If practice acceptable method birth control , confirmation negative pregnancy urine test female subject require Screening Visit . No special precaution require male subject levorphanol approve therapy chronic pain . 1 . Use opioid mixed agonistantagonists ( pentazocine , buprenorphine , butorphanol ) , tramadol , allow . Use intrathecal opioid infusion pump allow . 2 . Allergy levorphanol . 3 . Patients unable read speak English . 4 . A pain complaint , believe psychogenic nature confirm medical record physical examination . 5 . Pain due disease , cancer remission , expect substantially progress study period . 6 . Cognitive impairment , psychiatric disorder , unrelated neurological disorder severe enough interfere assessment pain sensory system . 7 . Pregnancy . 8 . Has receive investigational drug within 30 day prior Study Visit 2 . 9 . A current substance abuse disorder , positive urine drug screen , history opioid drug abuse time past . 10 . Intolerable side effect , fail achieve adequate analgesic effect prior attempt opioid dose escalation within range dos use study . 11 . Coexisting medical condition require medication use contraindicate study procedure opioid dose escalation . Subjects disorder , unusual skin fragility severe peripheral neuropathy contraindicate brief thermal sensitization allow participate without component . 12 . Those , opinion investigator , unlikely comply study protocol unsuitable reason .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Chronic Pain</keyword>
</DOC>